BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37642566)

  • 1. O-RADS US: A Systematic Review and Meta-Analysis of Category-specific Malignancy Rates.
    Lee S; Lee JE; Hwang JA; Shin H
    Radiology; 2023 Aug; 308(2):e223269. PubMed ID: 37642566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.
    Rizzo S; Cozzi A; Dolciami M; Del Grande F; Scarano AL; Papadia A; Gui B; Gandolfo N; Catalano C; Manganaro L
    Radiology; 2023 Apr; 307(1):e220795. PubMed ID: 36413127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
    Zhang Q; Dai X; Li W
    AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced US to Improve Diagnostic Performance of O-RADS US Risk Stratification System for Malignancy.
    Yuan K; Huang YJ; Mao MY; Li T; Wang SJ; He DN; Liu WF; Li MX; Zhu XM; Chen XY; Zhu YX
    Radiology; 2023 Aug; 308(2):e223003. PubMed ID: 37552073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Validation of O-RADS US Risk Stratification and Management System.
    Hack K; Gandhi N; Bouchard-Fortier G; Chawla TP; Ferguson SE; Li S; Kahn D; Tyrrell PN; Glanc P
    Radiology; 2022 Jul; 304(1):114-120. PubMed ID: 35438559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
    Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
    Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
    JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian Adnexal Reporting Data System (O-RADS) for Classifying Adnexal Masses: A Systematic Review and Meta-Analysis.
    Vara J; Manzour N; Chacón E; López-Picazo A; Linares M; Pascual MÁ; Guerriero S; Alcázar JL
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-RADS MRI Classification of Indeterminate Adnexal Lesions: Time-Intensity Curve Analysis Is Better Than Visual Assessment.
    Wengert GJ; Dabi Y; Kermarrec E; Jalaguier-Coudray A; Poncelet E; Porcher R; Thomassin-Naggara I; Rockall AG;
    Radiology; 2022 Jun; 303(3):566-575. PubMed ID: 35230183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Combing O-RADS US and CA-125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?
    Wu M; Wang Q; Zhang M; Cao J; Chen Y; Zheng J; Luo L; Su M; Lin X; Kuang X; Zhang X
    J Ultrasound Med; 2023 Feb; 42(3):675-685. PubMed ID: 35880406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United States.
    Jha P; Gupta A; Baran TM; Maturen KE; Patel-Lippmann K; Zafar HM; Kamaya A; Antil N; Barroilhet L; Sadowski EA
    JAMA Netw Open; 2022 Jun; 5(6):e2216370. PubMed ID: 35679042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-RADS US v2022: An Update from the American College of Radiology's Ovarian-Adnexal Reporting and Data System US Committee.
    Strachowski LM; Jha P; Phillips CH; Blanchette Porter MM; Froyman W; Glanc P; Guo Y; Patel MD; Reinhold C; Suh-Burgmann EJ; Timmerman D; Andreotti RF
    Radiology; 2023 Sep; 308(3):e230685. PubMed ID: 37698472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
    Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis.
    Spick C; Bickel H; Polanec SH; Baltzer PA
    Eur Radiol; 2018 May; 28(5):1919-1928. PubMed ID: 29168006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee.
    Andreotti RF; Timmerman D; Strachowski LM; Froyman W; Benacerraf BR; Bennett GL; Bourne T; Brown DL; Coleman BG; Frates MC; Goldstein SR; Hamper UM; Horrow MM; Hernanz-Schulman M; Reinhold C; Rose SL; Whitcomb BP; Wolfman WL; Glanc P
    Radiology; 2020 Jan; 294(1):168-185. PubMed ID: 31687921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Learning Prediction of Ovarian Malignancy at US Compared with O-RADS and Expert Assessment.
    Chen H; Yang BW; Qian L; Meng YS; Bai XH; Hong XW; He X; Jiang MJ; Yuan F; Du QW; Feng WW
    Radiology; 2022 Jul; 304(1):106-113. PubMed ID: 35412367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-RADS Ultrasound Version 1: A Scenario-Based Review of Implementation Challenges.
    Gargan ML; Frates MC; Benson CB; Guo Y
    AJR Am J Roentgenol; 2022 Dec; 219(6):916-927. PubMed ID: 35856453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interreader Agreement and Intermodality Concordance of O-RADS US and MRI for Assessing Large, Complex Ovarian-Adnexal Cysts.
    Guo Y; Phillips CH; Suarez-Weiss K; Roller LA; Frates MC; Benson CB; Shinagare AB
    Radiol Imaging Cancer; 2022 Sep; 4(5):e220064. PubMed ID: 36178350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.